第一作者:
Hiroyuki,Tsuchiya
第一单位:
Division of Medical Genetics and Regenerative Medicine, Department of Genomic Medicine and Regenerative Therapy, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.
作者:
关键词
ADCC, antibody-dependent cell mediated cytotoxicityALDH, alcohol dehydrogenaseAML, acute myeloid leukemiaARID3B, AT-rich interaction domain-containing protein 3BCCR7, C–C motif chemokine receptor 7CIK, cytokine-induced killer cellCMV, cytomegalovirusCSC, cancer stem cellCTL, cytotoxic T lymphocytesCTLA-4, cytotoxic T-cell-associated antigen-4Cancer stem cellsDC, dendritic cellDNMT, DNA methyltransferaseEMT, epithelial–mesenchymal transitionETO, fat mass and obesity associated proteinEV, extracellular vesicleHNSCC, head and neck squamous cell carcinomaImmune checkpointsImmune evasionKDM4, lysine-specific demethylase 4CKIR, killer immunoglobulin-like receptorLAG3, lymphocyte activation gene 3LILR, leukocyte immunoglobulin-like receptorLMP, low molecular weight proteinLOX, lysyl oxidaseMDSC, myeloid-derived suppressor cellMHC, major histocompatibility complexMIC, MHC class I polypeptide-related sequenceNGF, nerve growth factorNK cellsNK, natural killerNOD, nonobese diabeticNSG, NOD/SCID IL-2 receptor gamma chain nullOCT4, octamer-binding transcription factor 4PD-1, programmed death receptor-1PD-L1/2, ligands 1/2PI9, protease inhibitor 9PSME3, proteasome activator subunit 3SCID, severe combined immunodeficientSOX2, sex determining region Y-box 2T cellsTAM, tumor-associated macrophageTAP, transporter associated with antigen processingTCR, T cell receptorTreg, regulatory T cellULBP, UL16 binding proteinuPAR, urokinase-type plasminogen activator receptor
DOI
10.1016/j.reth.2021.02.006
PMID
33778133
发布时间
2024-08-08
- 浏览6

Regenerative therapy
2021年17卷
20-33页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文